A Ca2+-toolkit-specific transcriptomic analysis (Pérez-Riesgo et al. [97]) revealed that CACNA1D-expression was increased 1.55-fold in human colorectal cancer cells, compared to normal colon cells. The gene discussed is CACNA1D; the disease is colorectal cancer.